Characterization of the Organic Anion Transporter 2 (OAT2) and its interaction with cytostatics

被引：0
|
作者：
Yohannes, Hagos [1 ]
Marad, Venkata [1 ]
Floerl, Saskia [2 ]
Kuehne, Annett [2 ]
机构：
[1] Univ Goettingen, Gottingen, Germany
[2] PortaCellTec Biosci GmbH, Gottingen, Germany
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
732.7
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Identification of biopterins as novel substrates of the organic anion transporter OAT2
    Koelz, C.
    Dressler, J.
    Hofmann, U.
    Schwab, M.
    Nies, A. T.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S45 - S46
  • [2] Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs
    Marada, Venkata V. V. R.
    Florl, Saskia
    Kuhne, Annett
    Muller, Judith
    Burckhardt, Gerhard
    Hagos, Yohannes
    PHARMACOLOGICAL RESEARCH, 2015, 91 : 78 - 87
  • [3] Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones
    Ljubojevic, Marija
    Balen, Daniela
    Breljak, Davorka
    Kusan, Marija
    Anzai, Naohiko
    Bahn, Andrew
    Burckhardt, Gerhard
    Sabolic, Ivan
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 292 (01) : F361 - F372
  • [4] Renal Secretion of Uric Acid by Organic Anion Transporter 2 (OAT2/SLC22A7) in Human
    Sato, Masanobu
    Mamada, Hideaki
    Anzai, Naohiko
    Shirasaka, Yoshiyuki
    Nakanishi, Takeo
    Tamai, Ikumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (03) : 498 - 503
  • [5] Endoplasmic reticulum transporter OAT2 regulates drug metabolism and interaction
    Arakawa, Hiroshi
    Ishida, Naoki
    Nakatsuji, Tomoki
    Matsumoto, Natsumi
    Imamura, Rikako
    Shengyu, Dai
    Araya, Karin
    Horike, Shin-ichi
    Tanaka-Yachi, Rieko
    Kasahara, Mureo
    Yoshioka, Takako
    Sumida, Yuto
    Ohmiya, Hirohisa
    Daikoku, Takiko
    Wakayama, Tomohiko
    Nakamura, Kazuaki
    Fujita, Ken-ichi
    Kato, Yukio
    BIOCHEMICAL PHARMACOLOGY, 2024, 225
  • [6] In vitro studies with two human organic anion transporters: OAT2 and OAT7
    Mathialagan, Sumathy
    Costales, Chester
    Tylaska, Laurie
    Kimoto, Emi
    Vildhede, Anna
    Johnson, Jillian
    Johnson, Nathaniel
    Sarashina, Takami
    Hashizume, Kenta
    Isringhausen, Caleb D.
    Vermeer, Lydia M. M.
    Wolff, Andrea R.
    Rodrigues, A. David
    XENOBIOTICA, 2018, 48 (10) : 1037 - 1049
  • [7] In vitro and in silico characterization of the transport of selected perfluoroalkyl carboxylic acids and perfluoroalkyl sulfonic acids by human organic anion transporter 1 (OAT1), OAT2 and OAT3
    Louisse, Jochem
    Pedroni, Lorenzo
    van den Heuvel, Jeroen J. M. W.
    Rijkers, Deborah
    Leenders, Liz
    Noorlander, Annelies
    Punt, Ans
    Russel, Frans G. M.
    Koenderink, Jan B.
    Dellafiora, Luca
    TOXICOLOGY, 2024, 509
  • [8] Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney
    Kojima, R
    Sekine, T
    Kawachi, M
    Cha, SH
    Suzuki, Y
    Endou, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (04):
  • [9] Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat
    Lepist, Eve-Irene
    Zhang, Xuexiang
    Hao, Jia
    Huang, Jane
    Kosaka, Alan
    Birkus, Gabriel
    Murray, Bernard P.
    Bannister, Roy
    Cihlar, Tomas
    Huang, Yong
    Ray, Adrian S.
    KIDNEY INTERNATIONAL, 2014, 86 (02) : 350 - 357
  • [10] BEMPEDOIC ACID, A FIRST-IN-CLASS ADENOSINE TRIPHOSPHATE (ATP) CITRATE LYASE INHIBITOR, IS A HUMAN ORGANIC ANION TRANSPORTER 2 (OAT2) INHIBITOR.
    Emery, M.
    Cramer, C.
    Sasiela, W.
    Zhang, X.
    Warren, M.
    Tirona, R.
    Amore, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S81 - S81
12345